Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
PARKINSUN is a new communication aid tool, expected to favor global patient centered care for PD patients during consultation with GPs and neurologists. Two groups of patients will be randomized to use or not PARKINSUN when they consult their physicians every 3 months during 7 months.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
120 participants in 2 patient groups
Loading...
Central trial contact
David Devos, MD,PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal